----

----

| þ | QUARTERLY REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|-----------------------------------------------------------------------------------|

| o | TRANSITION REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|------------------------------------------------------------------------------------|

| SIONIX CORPORATION                                     |
|--------------------------------------------------------|
| (Exact name of registrant as specified in its charter) |

| Nevada                                                         |   | 87-0428526                          |
|----------------------------------------------------------------|--------|-------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No. |

| 914 Westwood Blvd., Box 801Los Angeles, California |   | 90024      |
|----------------------------------------------------|--------|------------|
| (Address of principal executive offices)           |   | (Zip Code) |

| Large accelerated filer                       | o      | Accelerated filer         | o      |
|-----------------------------------------------|--------|---------------------------|--------|
| Non-accelerated filer                         | o      | Smaller reporting company | þ |
| (Do not check if a smaller reporting company) |   |                      |   |

----

----

----

| Part I - Financial Information    |                                                                                                 |   | 3      |   |
|-----------------------------------|------------------------------------------------------------------------------------------------------|--------|--------|--------|
|                              |                                                                                                 |   |   |   |   |
| Item 1.                           | Financial Statements                                                                                 |   |   | 3      |   |
|                              |                                                                                                 |   |   |   |   |
|                              | (Unaudited) Balance Sheets as of June 30, 2011 and September 30, 2010                                |   |   | 3      |   |
|                              |                                                                                                 |   |   |   |   |
|                              | (Unaudited) Statements of Operations for the three and nine months ended June 30, 2011 and 2010 |   |   | 4      |   |
|                              |                                                                                                 |   |   |   |   |
|                              | (Unaudited) Statements of Cash Flows for the nine months ended June 30, 2011 and 2010           |   |   | 5      |   |
|                              |                                                                                                 |   |   |   |   |
|                              | Notes to unaudited condensed financial statements                                                    |   |   | 6      |   |
|                              |                                                                                                 |   |   |   |   |
|                              | Forward-Looking Statements                                                                           |   |   |   |   |
|                              |                                                                                                 |   |   |   |   |
| Item 2.                           | Management’s Discussion and Analysis of Financial Condition and Results of Operations          |   |   | 13     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 3.                           | Quantitative and Qualitative Disclosures About Market Risk                                           |   |   | 15     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 4.                           | Controls and Procedures                                                                              |   |   | 15     |   |
|                              |                                                                                                 |   |   |   |   |
| Part II – Other Information |                                                                                                 |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 1.                           | Legal Proceedings                                                                                    |   |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 1A.                          | Risk Factors                                                                                         |   |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 2.                           | Unregistered Sales of Equity Securities and Use of Proceeds                                          |   |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 3.                           | Defaults Upon Senior Securities                                                                      |   |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 4.                           | Reserved                                                                                             |   |   | 16     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 5.                           | Other Information                                                                                    |   |   | 17     |   |
|                              |                                                                                                 |   |   |   |   |
| Item 6.                           | Exhibits                                                                                             |   |   | 17     |   |
|                              |                                                                                                 |   |   |   |   |
| Signatures                        |                                                                                                 |   |   | 18     |   |

----

|                                                                                                                                                                                                                                          |   | As of June 30, |        |   | As of September 30, |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------|-------------|--------|--------------------------|--------|
|                                                                                                                                                                                                                                          |   | 2011           |        |   | 2010                     |   |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |
| ASSETS                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |
| Current assets:                                                                                                                                                                                                                               |   |           |        |   |                     |   |
|      Cash and cash equivalents                                                                                                                                                                                            |   | $              | -           |   |                     | $      | 23,084 |   |
|      Other receivable                                                                                                                                                                                                     |   |           | 7,742       |   |                     |   | 1,500 |   |
|      Inventory                                                                                                                                                                                                            |   |           | 1,191,849   |   |                     |   | 579,160 |   |
|      Other current assets                                                                                                                                                                                                 |   |           | 49,430      |   |                     |   | 11,750 |   |
|           Total current assets                                                                                                                                                                   |   |           | 1,249,021   |   |                     |   | 615,494 |   |
| Non-current assets:                                                                                                                                                                                                                           |   |           |        |   |                     |   |   |   |
|      Property and equipment, net                                                                                                                                                                                          |   |           | 33,024      |   |                     |   | 38,599 |   |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |   |   |
|           Total assets                                                                                                                                                                           |   | $              | 1,282,045   |   |                     | $      | 654,093 |   |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                                                                                                                                    |
| Current liabilities:                                                                                                                                                                                                                          |   |           |        |   |                     |   |   |   |
|      Bank overdraft                                                                                                                                                                                                       |   | $              | 278         |   |                     | $      | - |   |
|      Accounts payable                                                                                                                                                                                                     |   |           | 657,089     |   |                     |   | 215,842 |   |
|      Accrued expenses                                                                                                                                                                                                     |   |           | 683,162     |   |                     |   | 943,485 |   |
|      Deferred revenue                                                                                                                                                                                                     |   |           | -           |   |                     |   | 300,000 |   |
|      Notes payable - related parties                                                                                                                                                                                      |   |           | 25,000      |   |                     |   | 27,000 |   |
|      Convertible notes, net of debt discount                                                                                                                                                                              |   |           | 987,776     |   |                     |   | 1,470,776 |   |
|      10% subordinated convertible notes                                                                                                                                                                                   |   |           | -           |   |                     |   | 56,615 |   |
|      Shares to be issued                                                                                                                                                                                                  |   |           | -           |   |                     |   | - |   |
|      Derivative liability                                                                                                                                                                                                 |   |           | 221,266     |   |                     |   | 137,053 |   |
|           Total current liabilities                                                                                                                                                              |   |           | 2,574,571   |   |                     |   | 3,150,771 |   |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |   |   |
| Stockholders' deficit:                                                                                                                                                                                                                        |   |           |        |   |                     |   |   |   |
|      Preferred stock, $0.001 par value, 10,000,000 shares authorized at June 30, 2011                                                                                                                                     |   |           | -           |   |                     |   | - |   |
|      Common stock, $0.001 par value (600,000,000 shares authorized; 286,322,104 and 217,154,741 shares issued        and outstanding at June 30, 2011 and September 30, 2010, respectively) |   |           | 286,322     |   |                     |   | 217,155 |   |
|      Additional paid-in capital                                                                                                                                                                                           |   |           | 28,552,515  |   |                     |   | 22,885,234 |   |
|      Accumulated deficit                                                                                                                                                                                                  |   |           | (30,131,363 | )      |                     |   | (25,599,067 | ) |
|           Total stockholders' deficit                                                                                                                                                            |   |           | (1,292,526  | )      |                     |   | (2,496,678 | ) |
|                                                                                                                                                                                                                                          |   |           |        |   |                     |   |   |   |
|           Total liabilities and stockholders'  deficit                                                                                                                                 |   | $              | 1,282,045   |   |                     | $      | 654,093 |   |

----

|                                                                  |   | Three Months Ended June 30, |        |   | Nine Months Ended June 30, |   |
|-----------------------------------------------------------------------|--------|----------------------------------|-------------|--------|---------------------------------|--------|
|                                                                  |   | 2011                             |        |   | 2010                            |   |   | 2011 |   |   | 2010 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |
| Net revenues                                                          |   | $                                | -           |   |                            | $      | - |   |   | $ | - |   |   | $ | 1,620,000 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Cost of sales                                                         |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | 1,091,500 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Gross profit                                                          |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | 528,500 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Operating expenses                                                    |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| General and administrative                                            |   |                             | 740,281     |   |                            |   | 580,095 |   |   |   | 2,217,475 |   |   |   | 1,273,969 |   |
| Sales and marketing                                                   |   |                             | 131,674     |   |                            |   | 80,255 |   |   |   | 336,181 |   |   |   | 138,101 |   |
| Research and development                                              |   |                             | 296,009     |   |                            |   | 74,662 |   |   |   | 470,215 |   |   |   | 192,928 |   |
| Depreciation and amortization                                         |   |                             | 3,468       |   |                            |   | 5,708 |   |   |   | 8,702 |   |   |   | 18,284 |   |
| Total operating expenses                                              |   |                             | 1,171,432   |   |                            |   | 740,720 |   |   |   | 3,032,573 |   |   |   | 1,623,282 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| (Loss) income from operations                                         |   |                             | (1,171,432  | )      |                            |   | (740,720 | ) |   |   | (3,032,573 | ) |   |   | (1,094,782 | ) |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Other income (expense)                                                |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Interest expense and financing costs                                  |   |                             | (125,760    | )      |                            |   | (290,910 | ) |   |   | (321,373 | ) |   |   | (740,507 | ) |
| Gain (loss) on change in fair value of:                               |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Derivative liability                                                  |   |                             | (2,618      | )      |                            |   | - |   |   |   | (25,075 | ) |   |   | - |   |
| Warrant and option liability                                          |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | 4,359,957 |   |
| Beneficial conversion liability                                       |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | 959,985 |   |
| Other income                                                          |   |                             | -           |   |                            |   | - |   |   |   | 470,132 |   |   |   | - |   |
| Legal settlements                                                     |   |                             | -           |   |                            |   | - |   |   |   | (236,821 | ) |   |   | - |   |
| Gain (loss) on settlement of debt                                     |   |                             | (1,312,315  | )      |                            |   | (608,625 | ) |   |   | (1,386,586 | ) |   |   | (578,625 | ) |
| Loss on lease termination                                             |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | (197,455 | ) |
| Loss on asset disposition                                             |   |                             | -           |   |                            |   | - |   |   |   | - |   |   |   | (11,217 | ) |
| Total other income (expense)                                          |   |                             | (1,440,693  | )      |                            |   | (899,535 | ) |   |   | (1,499,723 | ) |   |   | 3,792,138 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| (Loss) income before income taxes                                     |   |                             | (2,612,125  | )      |                            |   | (1,640,255 | ) |   |   | (4,532,296 | ) |   |   | 2,697,356 |   |
| Income taxes                                                          |   |                             | -           |   |                            |   | (1,600 | ) |   |   | - |   |   |   | (1,600 | ) |
| Net (loss) income attributable to common shareholders                 |   | $                                | (2,612,125  | )      |                            | $      | (1,641,855 | ) |   | $ | (4,532,296 | ) |   | $ | 2,695,756 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Basic (loss) income per share                                         |   | $                                | (0.01       | )      |                            | $      | (0.01 | ) |   | $ | (0.02 | ) |   | $ | 0.02 |   |
| Diluted (loss) income per share                                       |   | $                                | (0.01       | )      |                            | $      | (0.01 | ) |   | $ | (0.02 | ) |   | $ | 0.03 |   |
|                                                                  |   |                             |        |   |                            |   |   |   |   |   |   |   |   |   |   |   |
| Basic weighted average number of shares of common stock outstanding   |   |                             | 265,479,323 |   |                            |   | 151,655,634 |   |   |   | 244,657,656 |   |   |   | 149,677,378 |   |
| Diluted weighted average number of shares of common stock outstanding |   |                             | 265,479,323 |   |                            |   | 151,655,634 |   |   |   | 244,657,656 |   |   |   | 180,710,139 |   |

----

|                                                                                 |   | Nine Months Ended June 30, |       |
|--------------------------------------------------------------------------------------|--------|---------------------------------|------------|
|                                                                                 |   | 2011                            |       |   | 2010 |   |
|                                                                                 |   |                            |       |   |   |   |
| Cash flows from operating activities                                                 |   |                            |       |   |   |   |
| Net (loss) income                                                                    |   | $                               | (4,532,296 | ) |   | $ | 2,695,756 |   |
| Adjustments to reconcile net (loss) income to net cash used by operating activities: |   |                            |       |   |   |   |   |   |
| Depreciation                                                                         |   |                            | 8,702      |   |   |   | 18,284 |   |
| Amortization of beneficial conversion feature and debt discounts                     |   |                            | 142,248    |   |   |   | 477,203 |   |
| Share based payments                                                                 |   |                            | 682,832    |   |   |   | 433,456 |   |
| Common stock issued for services                                                     |   |                            | 1,127,050  |   |   |   | 588,732 |   |
| (Gain) loss on change in fair value of:                                              |   |                            |       |   |   |   |   |   |
| Derivative liability                                                                 |   |                            | 25,075     |   |   |   | - |   |
| Warrant and option liability                                                         |   |                            | -          |   |   |   | (4,359,957 | ) |
| Beneficial conversion liability                                                      |   |                            | -          |   |   |   | (959,985 | ) |
| (Gain) loss on settlement of debt                                                    |   |                            | 1,386,586  |   |   |   | 578,625 |   |
| Loss on termination of lease                                                         |   |                            | -          |   |   |   |   |   |
| Impairment of property and equipment                                                 |   |                            | -          |   |   |   | 11,217 |   |
| (Increase) decrease in:                                                              |   |                            |       |   |   |   |   |   |
| Inventory                                                                            |   |                            | (612,689   | ) |   |   | 875,404 |   |
| Other current assets                                                                 |   |                            | (48,828    | ) |   |   | (69,802 | ) |
| Other assets                                                                         |   |                            | -          |   |   |   | 25,950 |   |
| Increase (decrease) in:                                                              |   |                            |       |   |   |   |   |   |
| Accounts payable                                                                     |   |                            | 219,542    |   |   |   | (55,094 | ) |
| Accrued expenses                                                                     |   |                            | (45,957    | ) |   |   | 380,275 |   |
| Deferred revenue                                                                     |   |                            | (300,000   | ) |   |   | (1,620,000 | ) |
| Net cash used by operating activities                                                |   |                            | (1,947,735 | ) |   |   | (979,936 | ) |
|                                                                                 |   |                            |       |   |   |   |   |   |
| Cash flows from investing activities:                                                |   |                            |       |   |   |   |   |   |
| Purchase of property and equipment                                                   |   |                            | (3,127     | ) |   |   | - |   |
| Cash flows from financing activities:                                                |   |                            |       |   |   |   |   |   |
| Borrowings                                                                           |   |                            | 195,278    |   |   |   | 510,000 |   |
| Common stock issued for cash                                                         |   |                            | 1,732,500  |   |   |   | 450,000 |   |
| Net cash provided by financing activities                                            |   |                            | 1,927,778  |   |   |   | 960,000 |   |
|                                                                                 |   |                            |       |   |   |   |   |   |
| Net (decrease) increase in cash and cash equivalents                                 |   |                            | (23,084    | ) |   |   | (19,936 | ) |
| Cash and cash equivalents, beginning of period                                       |   |                            | 23,084     |   |   |   | 22,982 |   |
| Cash and cash equivalents, end of period                                             |   | $                               | -          |   |   | $ | 3,046 |   |
|                                                                                 |   |                            |       |   |   |   |   |   |
| SUPPLEMENTARY CASH FLOW INFORMATION:                                                 |   |                            |       |   |   |   |   |   |
| Income taxes paid                                                                    |   | $                               | 2,569      |   |   | $ | - |   |
| Interest paid                                                                        |   | $                               | -          |   |   | $ | - |   |

----

----

|                                             |   | For the Nine Months Ended June 30, 2010 |      |
|--------------------------------------------------|--------|---------------------------------------------------|-----------|
|                                             |   | Income (Numerator)                                |      |   | Weighted Average Number of Shares (Denominator) |   |   | Amount per Share |   |
|                                             |   |                                              |      |   |   |   |   |   |   |
| Basic Earnings Per Share                         |   |                                              |      |   |   |   |   |   |   |
| Income available to common stockholders          |   | $                                                 | 2,695,756 |   |   |   | 149,677,378 |   |   | $ | 0.02 |   |
| Effect of Dilutive Securities                    |   |                                              |      |   |   |   |   |   |   |   |   |   |
| Stock options                                    |   |                                              | -         |   |   |   | 632,194 |   |   |   |   |   |
| Warrants                                         |   |                                              | -         |   |   |   | 864,793 |   |   |   |   |   |
| Convertible debt                                 |   |                                              | 684,370   |   |   |   | 29,535,774 |   |   |   |   |   |
|                                             |   |                                              |      |   |   |   |   |   |   |   |   |   |
| Diluted Earnings Per Share                       |   |                                              |      |   |   |   |   |   |   |   |   |   |
| Adjusted income available to common stockholders |   | $                                                 | 3,380,126 |   |   |   | 180,710,139 |   |   | $ | 0.02 |   |

----

|                          |   | June 30, |   |   | September 30, |   |
|-------------------------------|--------|---------------|--------|--------|--------------------|--------|
|                          |   | 2011          |   |   | 2010               |   |
|                          |   |          |   |   |               |   |
| Machinery and equipment       |   | $             | 41,726 |   |               | $      | 38,599 |   |
| Less accumulated depreciation |   |          | (8,702 | )      |               |   | - |   |
|                          |   |          |   |   |               |   |   |   |
| Property and equipment, net   |   | $             | 33,024 |   |               | $      | 38,599 |   |

|                   |   | June 30, |    |   | September 30, |   |
|------------------------|--------|---------------|---------|--------|--------------------|--------|
|                   |   | 2011          |    |   | 2010               |   |
|                   |   |          |    |   |               |   |
| Accrued salaries       |   | $             | 212,066 |   |               | $      | 77,000 |   |
| Interest payable       |   |          | 208,763 |   |               |   | 256,777 |   |
| Claims payable         |   |          | 33,925  |   |               |   | 290,000 |   |
| Other accrued expenses |   |          | 228,408 |   |               |   | 319,708 |   |
|                   |   |          |    |   |               |   |   |   |
| Total accrued expenses |   | $             | 683,162 |   |               | $      | 943,485 |   |

----

----

|                           |   |       |       |   | Average  |   |   | Aggregate |   |   | Remaining   |   |
|--------------------------------|--------|------------|------------|--------|----------|--------|--------|-----------|--------|--------|-------------|--------|
|                           |   | Number     |       |   | Exercise |   |   | Intrinsic |   |   | Contractual |   |
|                           |   | of Options |       |   | Price    |   |   | Value     |   |   | Life        |   |
|                           |   |       |       |   |     |   |   |      |   |   |        |   |
| Outstanding at October 1, 2010 |   |       | 24,501,316 |   |     | $      | 0.13   |      |   | $      | -           |   |   |   | 2.55 |   |
| Granted                        |   |       | 13,365,000 |   |     |   | 0.10   |      |   |   |        |   |   |   |   |   |
| Expired                        |   |       | -          |   |     |   | -      |      |   |   |        |   |   |   |   |   |
| Forfeited                      |   |       | -          |   |     |   | -      |      |   |   |        |   |   |   |   |   |
| Exercised                      |   |       | -          |   |     |   | -      |      |   |   |        |   |   |   |   |   |
| Outstanding at June 30, 2011   |   |       | 37,866,316 |   |     | $      | 0.12   |      |   | $      | 722,237     |   |   |   | 3.22 |   |
|                           |   |       |       |   |     |   |   |      |   |   |        |   |   |   |   |   |
| Exercisable at June 30, 2011   |   |       | 37,302,645 |   |     | $      | 0.12   |      |   | $      | 717,956     |   |   |   | 3.19 |   |

|     |   |        |       | Weighted    |   |        |   | Weighted    |   |
|----------|--------|-------------|------------|-------------|--------|-------------|--------|-------------|--------|
|     |   |        |       | Average     |   |        |   | Average     |   |
|     |   |        |       | Remaining   |   |        |   | Remaining   |   |
| Exercise |   | Options     |       | Contractual |   | Options     |   | Contractual |   |
| Price    |   | Outstanding |       | Life        |   | Exercisable |   | Life        |   |
| $        | 0.06   |        | 6,565,000  |        |   | 4.02        |   | 6,493,658   |   |   | 4.01 |   |
| $        | 0.07   |        | 2,000,000  |        |   | 4.51        |   | 2,000,000   |   |   | 4.51 |   |
| $        | 0.09   |        | 2,000,000  |        |   | 4.51        |   | 2,000,000   |   |   | 4.51 |   |
| $        | 0.10   |        | 8,416,850  |        |   | 2.85        |   | 8,416,850   |   |   | 2.85 |   |
| $        | 0.12   |        | 8,450,940  |        |   | 2.79        |   | 8,450,940   |   |   | 2.79 |   |
| $        | 0.14   |        | 500,000    |        |   | 3.31        |   | 7,671       |   |   | 3.31 |   |
| $        | 0.15   |        | 7,000,000  |        |   | 3.31        |   | 7,000,000   |   |   | 3.31 |   |
| $        | 0.25   |        | 2,933,526  |        |   | 1.47        |   | 2,933,526   |   |   | 1.47 |   |
|     |   |        | 37,866,316 |        |   | 3.22        |   | 37,302,645  |   |   | 3.19 |   |

----

| ·  | risk free rate of return of 0.44 – 2.24%; |
|--------------|-------------------------------------------------|

| ·  | volatility of 152 – 190% |
|--------------|--------------------------------|

| ·  | dividend yield of 0%; and |
|--------------|---------------------------|

| ·  | expected term of 5 years. |
|--------------|---------------------------|

|                            |   |        |       |   | Weighted |   |   |      |   |
|---------------------------------|--------|-------------|------------|--------|----------|--------|--------|-----------|--------|
|                            |   |        |       |   | Average  |   |   | Aggregate |   |
|                            |   | Number      |       |   | Exercise |   |   | Intrinsic |   |
|                            |   | of Warrants |       |   | Price    |   |   | Value     |   |
| Outstanding at October 1, 2010  |   |        | 65,238,820 |   |     | $      | 0.18   |      |   | $ | - |   |
| Granted                         |   |        | 31,929,161 |   |     |   | 0.14   |      |   |   |   |   |
| Expired                         |   |        | -          |   |     |   | -      |      |   |   |   |   |
| Forfeited                       |   |        | (833,333   | )      |     |   | -      |      |   |   |   |   |
| Exercised                       |   |        | (500,000   | )      |     |   | -      |      |   |   |   |   |
| Outstanding as of June 30, 2011 |   |        | 95,834,648 |   |     | $      | 0.16   |      |   | $ | 1,174,344 |   |
|                            |   |        |       |   |     |   |   |      |   |   |   |   |
| Exercisable as of June 30, 2011 |   |        | 95,834,648 |   |     | $      | 0.16   |      |   | $ | 1,174,344 |   |

----

|     |   |   |        |   |       |        |   |   | Weighted    |   |   |             |   |   |        |   |
|----------|--------|--------|-------------|--------|------------|-------------|--------|--------|-------------|--------|--------|------------------|--------|--------|-------------|--------|
|     |   |   |        |   |       |        |   |   | Average     |   |   |             |   |   |        |   |
|     |   |   |        |   |       |        |   |   | Remaining   |   |   | Weighted Average |   |
| Exercise |   |   | Warrants    |   |       | Warrants    |   |   | Contractual |   |   | Exercise Price   |   |
| Price    |   |   | Outstanding |   |       | Exercisable |   |   | Life        |   |   | Outstanding      |   |   | Exercisable |   |
|     |   |   |        |   |       |        |   |   |        |   |   |             |   |   |        |   |
| $        | 0.06   |   |        |   | 7,500,000  |        |   |   | 7,500,000   |   |   |             | 4.89   |   |        | $      | 0.06 |   |   | $ | 0.06 |   |
| $        | 0.07   |   |        |   | 8,333,333  |        |   |   | 8,333,333   |   |   |             | 3.88   |   |        | $      | 0.07 |   |   | $ | 0.07 |   |
| $        | 0.10   |   |        |   | 15,383,889 |        |   |   | 15,383,889  |   |   |             | 1.10   |   |        | $      | 0.10 |   |   | $ | 0.10 |   |
| $        | 0.12   |   |        |   | 5,760,000  |        |   |   | 5,760,000   |   |   |             | 2.23   |   |        | $      | 0.12 |   |   | $ | 0.12 |   |
| $        | 0.14   |   |        |   | 5,000,000  |        |   |   | 5,000,000   |   |   |             | 4.32   |   |        | $      | 0.14 |   |   | $ | 0.14 |   |
| $        | 0.15   |   |        |   | 2,107,667  |        |   |   | 2,107,667   |   |   |             | 3.33   |   |        | $      | 0.15 |   |   | $ | 0.15 |   |
| $        | 0.17   |   |        |   | 24,574,993 |        |   |   | 24,574,993  |   |   |             | 4.53   |   |        | $      | 0.17 |   |   | $ | 0.17 |   |
| $        | 0.18   |   |        |   | 850,000    |        |   |   | 850,000     |   |   |             | 1.54   |   |        | $      | 0.18 |   |   | $ | 0.18 |   |
| $        | 0.25   |   |        |   | 21,029,312 |        |   |   | 21,029,312  |   |   |             | 1.64   |   |        | $      | 0.25 |   |   | $ | 0.25 |   |
| $        | 0.30   |   |        |   | 5,295,454  |        |   |   | 5,295,454   |   |   |             | 1.30   |   |        | $      | 0.30 |   |   | $ | 0.30 |   |
|     |   |   |        |   |       |        |   |   |        |   |   |             |   |   |        |   |   |   |   |   |   |   |
|     |   |   |        |   | 95,834,648 |        |   |   | 95,834,648  |   |   |             |   |   |        |   |   |   |   |   |   |   |

----

| · | our inability to obtain the financing we need to continue our operations; |
|--------|---------------------------------------------------------------------------|

| · | changes in regulatory requirements that adversely affect our business; |
|--------|------------------------------------------------------------------------|

| · | loss of our key personnel; and |
|--------|--------------------------------|

| · | risks over which we have no control, such as the general global downturn in the economy which may adversely affect spending by government agencies. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| · | Issued 15,882,249 shares of common stock for conversion of debt in the amount of $801,991 (including interest). We relied on Section 3(a)(9) of the Securities Act as providing an exemption from registering the issuance of these shares of common stock under the Securities Act inasmuch as the conversion was made with our existing security holders exclusively and no commission or other remuneration was paid or given directly or indirectly for soliciting the exchange. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Issued 21,191,666 shares of common stock together with warrants to purchase 10,595,829 shares of common stock, for gross proceeds of $1,271,500 ($0.06 per share). We relied on Section 4(2) of the Securities Act, as providing an exemption from registering the sale of these shares of common stock under the Securities Act. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Exhibit No. |   | Description of Exhibit                                                                                                  |
|-------------|--------|-------------------------------------------------------------------------------------------------------------------------|
|        |   |                                                                                                                    |
| 3.1         |   | Articles of Incorporation (1)                                                                                           |
|        |   |                                                                                                                    |
| 3.1.1       |   | Amendment to Articles of Incorporation (2)                                                                              |
|        |   |                                                                                                                    |
| 3.2         |   | Bylaws (1)                                                                                                              |
|        |   |                                                                                                                    |
| 31.1        |   | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*                                                |
|        |   |                                                                                                                    |
| 31.2        |   | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*                                                |
|        |   |                                                                                                                    |
| 32.1        |   | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
|        |   |                                                                                                                    |
| 32.2        |   | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |

| (1) | Incorporated by reference from our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 15, 2003 as file number 002-95626-D. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference from Annex 1 to our definitive proxy statement filed with the Securities and Exchange Commission on February 7, 2010 as file number 002-95626-D. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                  | SIONIX CORPORATION |                                                                                                    |
|-----------------------|--------------------|---------------------------------------------------------------------------------------------------------|
|                  |               |                                                                                                    |   |
| Date: August 15, 2011 | By:                | /s/ David R. Wells                                                                                      |   |
|                  |               | David R. Wells                                                                                          |   |
|                  |               | President, Chief Financial Officer, Secretary/Treasurer, and Principal Financial and Accounting Officer |   |